John Krug is an Executive Director and Site Quality Leader at Eli Lilly and Company, focusing on Indianapolis Device Manufacturing since 2024. Previously, they served as the Global Head of Quality Management and Post Market Surveillance at Roche Diabetes Care from 2022 to 2024 and held various leadership roles within Roche Diagnostics, including Sr. Director of Quality from 2017 to 2022. John also worked as a Post-doctoral Fellow at the National Institute of Standards and Technology in 2004-2005 and held positions at Roche Molecular Systems and Roche Diagnostics earlier in their career.
This person is not in any teams
This person is not in any offices